NVSEF
Price
$121.59
Change
-$4.74 (-3.75%)
Updated
Jul 3 closing price
Capitalization
216.52B
SNYNF
Price
$98.33
Change
+$1.68 (+1.74%)
Updated
Jul 3 closing price
Capitalization
134.16B
Interact to see
Advertisement

NVSEF vs SNYNF

Header iconNVSEF vs SNYNF Comparison
Open Charts NVSEF vs SNYNFBanner chart's image
Novartis AG
Price$121.59
Change-$4.74 (-3.75%)
Volume$50.01K
Capitalization216.52B
Sanofi
Price$98.33
Change+$1.68 (+1.74%)
Volume$327
Capitalization134.16B
NVSEF vs SNYNF Comparison Chart in %
Loading...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVSEF vs. SNYNF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVSEF is a Buy and SNYNF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (NVSEF: $121.60 vs. SNYNF: $98.33)
Brand notoriety: NVSEF and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVSEF: 2414% vs. SNYNF: 1%
Market capitalization -- NVSEF: $216.52B vs. SNYNF: $134.16B
NVSEF [@Pharmaceuticals: Major] is valued at $216.52B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVSEF’s FA Score shows that 3 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • NVSEF’s FA Score: 3 green, 2 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, NVSEF is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVSEF’s TA Score shows that 3 TA indicator(s) are bullish while SNYNF’s TA Score has 4 bullish TA indicator(s).

  • NVSEF’s TA Score: 3 bullish, 3 bearish.
  • SNYNF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both NVSEF and SNYNF are a good buy in the short-term.

Price Growth

NVSEF (@Pharmaceuticals: Major) experienced а +5.62% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($217B) has a higher market cap than SNYNF($134B). NVSEF has higher P/E ratio than SNYNF: NVSEF (29.50) vs SNYNF (14.04). NVSEF YTD gains are higher at: 26.530 vs. SNYNF (3.398). NVSEF has higher annual earnings (EBITDA): 17.8B vs. SNYNF (13.8B). NVSEF has more cash in the bank: 11.2B vs. SNYNF (7.99B). SNYNF has less debt than NVSEF: SNYNF (21B) vs NVSEF (28.3B). NVSEF has higher revenues than SNYNF: NVSEF (53.1B) vs SNYNF (46.1B).
NVSEFSNYNFNVSEF / SNYNF
Capitalization217B134B162%
EBITDA17.8B13.8B129%
Gain YTD26.5303.398781%
P/E Ratio29.5014.04210%
Revenue53.1B46.1B115%
Total Cash11.2B7.99B140%
Total Debt28.3B21B135%
FUNDAMENTALS RATINGS
NVSEF vs SNYNF: Fundamental Ratings
NVSEF
SNYNF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
2886
SMR RATING
1..100
2975
PRICE GROWTH RATING
1..100
4658
P/E GROWTH RATING
1..100
8089
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (8) in the null industry is in the same range as NVSEF (19). This means that SNYNF’s stock grew similarly to NVSEF’s over the last 12 months.

NVSEF's Profit vs Risk Rating (28) in the null industry is somewhat better than the same rating for SNYNF (86). This means that NVSEF’s stock grew somewhat faster than SNYNF’s over the last 12 months.

NVSEF's SMR Rating (29) in the null industry is somewhat better than the same rating for SNYNF (75). This means that NVSEF’s stock grew somewhat faster than SNYNF’s over the last 12 months.

NVSEF's Price Growth Rating (46) in the null industry is in the same range as SNYNF (58). This means that NVSEF’s stock grew similarly to SNYNF’s over the last 12 months.

NVSEF's P/E Growth Rating (80) in the null industry is in the same range as SNYNF (89). This means that NVSEF’s stock grew similarly to SNYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSEFSNYNF
RSI
ODDS (%)
Bearish Trend 5 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
42%
Bullish Trend 5 days ago
40%
Momentum
ODDS (%)
Bullish Trend 5 days ago
53%
Bullish Trend 5 days ago
46%
MACD
ODDS (%)
Bullish Trend 5 days ago
60%
Bullish Trend 5 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
49%
Bullish Trend 5 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
48%
Bullish Trend 5 days ago
48%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
48%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
45%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
53%
Bearish Trend 5 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTLS173.635.48
+3.26%
Chart Industries
NRDY1.670.04
+2.45%
Nerdy
XOM112.201.15
+1.04%
Exxon Mobil Corp
CFSB13.75-0.01
-0.07%
CFSB Bancorp
SILA24.02-0.02
-0.08%
Sila Realty Trust Inc.

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
-3.76%
SNYNF - NVSEF
26%
Poorly correlated
+1.74%
GIKLY - NVSEF
7%
Poorly correlated
N/A
KYKOF - NVSEF
5%
Poorly correlated
N/A
OPHLY - NVSEF
2%
Poorly correlated
-0.85%
GLAXF - NVSEF
1%
Poorly correlated
-1.56%
More

SNYNF and

Correlation & Price change

A.I.dvisor tells us that SNYNF and NVSEF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYNF and NVSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
+1.74%
NVSEF - SNYNF
27%
Poorly correlated
-3.76%
BIIB - SNYNF
21%
Poorly correlated
-0.24%
OGN - SNYNF
17%
Poorly correlated
-1.87%
SCLX - SNYNF
7%
Poorly correlated
+1.92%
MIRA - SNYNF
4%
Poorly correlated
-3.23%
More